Sanofi-aventis has signed a multi-year research pact with Stanford University Bio-X to support, conduct and facilitates interdisciplinary, collaborative and research projects in the early phases of development.
Subscribe to our email newsletter
As per the terms of the pact, both the parties are expected to fund up to five programs a year.
Sanofi-aventis may also host postdoctoral fellows at the company and Sanofi-aventis scientists may also be invited by Stanford faculty to be visiting scholars and to pursue research collaborations at Stanford.
Additionally, Sanofi-aventis will fund an annual research forum that will bring together Sanofi-aventis and Bio-X researchers to share knowledge and perspectives on relevant scientific matters and to discuss research projects funded through the collaboration.
Sanofi-aventis US senior vice president, chief science officer and chief medical officer Paul Chew said Bio-X researchers are exploring novel approaches needed in science today to accelerate the potential for scientific breakthroughs.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.